Filter

Refine by collections

  • Metabolic Syndrome and Diabetes (2)

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 2 of 2 items for :

  • "incretin-based therapy" x
  • Metabolic Syndrome and Diabetes x
Clear All
Svjatoslavs Kistkins Pauls Stradiņš Clinical University Hospital, Riga, Latvia

Search for other papers by Svjatoslavs Kistkins in
Google Scholar
PubMed Close
,
Othmar Moser Division of Exercise Physiology and Metabolism, Institute of Sport Science, University of Bayreuth, Bayreuth, Germany

Search for other papers by Othmar Moser in
Google Scholar
PubMed Close
,
Vitālijs Ankudovičs Pauls Stradiņš Clinical University Hospital, Riga, Latvia

Search for other papers by Vitālijs Ankudovičs in
Google Scholar
PubMed Close
,
Dmitrijs Blizņuks Institute of Smart Computing Technologies, Riga Technical University, Riga, Latvia

Search for other papers by Dmitrijs Blizņuks in
Google Scholar
PubMed Close
,
Timurs Mihailovs Institute of Smart Computing Technologies, Riga Technical University, Riga, Latvia

Search for other papers by Timurs Mihailovs in
Google Scholar
PubMed Close
,
Sergejs Lobanovs Pauls Stradiņš Clinical University Hospital, Riga, Latvia

Search for other papers by Sergejs Lobanovs in
Google Scholar
PubMed Close
,
Harald Sourij Trials Unit for Interdisciplinary Metabolic Medicine, Division of Endocrinology and Diabetolgoy, Medical University of Graz, Graz, Austria

Search for other papers by Harald Sourij in
Google Scholar
PubMed Close
,
Andreas F H Pfeiffer Department of Endocrinology and Metabolic Medicine, Campus Benjamin Franklin, Charité University Medicine, Hindenburgdamm, Berlin, Germany

Search for other papers by Andreas F H Pfeiffer in
Google Scholar
PubMed Close
, and
Valdis Pīrāgs Pauls Stradiņš Clinical University Hospital, Riga, Latvia
Faculty of Medicine, University of Latvia, Riga, Latvia

Search for other papers by Valdis Pīrāgs in
Google Scholar
PubMed Close

perspectives in the combinatory use of incretin-based therapies in diabesity and physiological nature of hormonal crosstalk The primary objective of treating diabetes in particular novel pharmacological options leading to significant weight loss is to enhance

Article Type:
Review Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-23-0529
Volume/Issue:
Volume 13: Issue 5
Open access
Shaomin Shi Division of Nephrology, The First Affiliated Hospital of Yangtze University, Jingzhou, China

Search for other papers by Shaomin Shi in
Google Scholar
PubMed Close
,
Xinghua Chen Division of Nephrology, Renmin Hospital of Wuhan University, Wuhan, China

Search for other papers by Xinghua Chen in
Google Scholar
PubMed Close
,
Wen Yu Department of Immunology, School of Medicine, Yangtze University, Jingzhou, China

Search for other papers by Wen Yu in
Google Scholar
PubMed Close
,
Xiaolan Ke Division of Nephrology, The First Affiliated Hospital of Yangtze University, Jingzhou, China

Search for other papers by Xiaolan Ke in
Google Scholar
PubMed Close
, and
Tean Ma Division of Nephrology, The First Affiliated Hospital of Yangtze University, Jingzhou, China

Search for other papers by Tean Ma in
Google Scholar
PubMed Close

& Sahebkar A . Renoprotective effects of incretin-based therapy in diabetes mellitus . BioMed Research International 2021 2021 8163153 . ( https://doi.org/10.1155/2021/8163153 ) 30 Guo H Wang B Li H Ling L Niu J & Gu Y . Glucagon

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-23-0284
Volume/Issue:
Volume 12: Issue 10
Open access